Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Eyestem Research has secured approval from India's CDSCO to begin Phase 2 clinical trials for its Eyecyte-RPE cell thera...
Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
US health insurance stocks today: Stocks of major US health insurance companies like UnitedHealth, Humana, and CVS fell ...
Neurosurgeon Dr. Brian Hoeflinger stresses sleep's vital role in brain health and performance, not as a luxury but a nec...
Medical inflation in India is soaring, making health insurance unaffordable and leading to higher out-of-pocket expenses...
Ankur Warikoo shares a new way to manage emotional energy. He suggests dividing your energy into three parts. Fifty perc...
France's National Assembly has backed legislation to ban children under 15 from social media, mirroring Australia's rece...
Live updates on markets and the top finance, economics and business stories. Plus the latest on the Dow, S&P 500 and Nas...
Minnesota shooting: Corporate leaders in Minnesota are breaking their silence on immigration enforcement after federal a...
The industrial real estate sector has outperformed, but may face tougher going now.